BSU scientist’s paper is included in «Frontiers in Clinical Drug Research» book by Bentham publishing house
_2.png)
The scientific article entitled "Emerging Nanotherapeutic Strategies in Alzheimer's Disease", by Professor Rovshan Khalilov, Head of the Department of Biophysics and Biochemistry of Baku State University (BSU), was included in the book "Frontiers in Clinical Drug Research", which was published by Bentham publishing house.
Recent nanotechnological advancements have opened new windows of hope for the treatment of neurodegenerative diseases and all of these new methods are rapidly evolving. Alzheimer's disease (AD) treatment based on neuroprotective and neurogenerative techniques has been advancing rapidly in recent decades, and the use of nanotechnology developments such as polymers, emulsions, lipo-carriers, solid lipid carriers, carbon nanotubes, and metal-based carriers has been very effective in both diagnosis and treatment methods. Targeted drug delivery is one of the most important concerns in the AD treatment approaches because the ‘blood-brain barrier’ or the ‘blood-cerebrospinal fluid barrier is a serious obstacle for delivering a therapeutic agent to the desired location, but the use of nanocarriers have provided acceptable results in this area. It seems that the use of nanotechnology in approving a successful treatment method for Alzheimer's is inevitable and this review has collected a complete copy of the recent nanotechnology-based approaches for the treatment of AD.